Recent Headlines
Within Biotechnology
Altogen Biosystems Develops Powerful In Vivo RNAi Research Tool for Oncology
Lipid-based liposomes of nanometer size are one of the most powerful molecules for delivery of novel therapeutics into target tissues enabling targeted cancer therapeutics. Pharma companies actively investigating new RNAi-based therapeutics where cargo molecules such as a small proteins, DNA,... - October 13, 2015 - Altogen Biosystems
T-Cell Immunotherapy Market to be Worth USD 30 Billion by 2030, Predicts Roots Analysis
The “T-Cell Immunotherapy Market, 2015-2030” report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the market segmented into the following three sub-groups: CAR-T therapies, TCR therapies and TIL therapies. - October 13, 2015 - Roots Analysis
CHI to Host Roundtable Discussions at Optimizing Bioassays for Biologics Conference
Moderated by Drs. Han Li, Bristol-Myers Squibb; Maura C. Kibbey, United States Pharmacopeia (USP); and Max L. Tejada, Gilead Sciences - October 10, 2015 - Cambridge Healthtech Institute
Bioo Scientific Showcases Solutions Designed to Improve Exome Capture at ASHG 2015
At ASHG 2015, Bioo Scientific is launching a number of new kits for the improvement of in-solution exome and custom target capture. These kits offer optimized library prep, blocking and barcoding, interfacing with Agilent SureSelect XT and XT2 systems and Roche’s Nimblegen SeqCap systems. ASHG is the largest human genetics meeting and expo worldwide, providing a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. - October 09, 2015 - Bioo Scientific
Public Health of Castilla La Mancha Opts for the Legipid Rapid Test for Detecting Legionella in Water
The Public Health Laboratories of Castilla La Mancha (Spain) have introduced the Legipid® Legionella Fast Detection kit to determine Legionella in water. This kit was developed by the company Biotica Bioquimica Analitica (www.biotica.es), which belongs to the Science, Technology and Business Park of the Universitat Jaume I (Espaitec). - October 08, 2015 - Biotica Bioquimica Analitica
Procyrion Inc. Earns €30,000 for Circulatory Support Pump in International Life Sciences Competition
Houston heart pump developer Procyrion Inc. (http://www.procyrion.com) earned the 2015 Universal Biotech Innovation Prize for Aortix™, a catheter-based circulatory support device. With the top two most innovative projects, Procyrion and Pixium Vision, will share a grant award and a year of... - October 08, 2015 - Procyrion Inc
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Northern California Motorcyclists Ride for Kids with Brain Tumors
Nearly 200 motorcyclists gathered for the Northern California Ride for Kids over the weekend to support children battling brain tumors. As of ride time, the family-friendly motorcycle event in Fairfield, Calif., had raised $59,342 to support the Pediatric Brain Tumor Foundation. The event honored... - October 07, 2015 - Pediatric Brain Tumor Foundation
Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals
ELISA Biology Contract Research Services Provided by Altogen Labs
Enzyme Linked Immunosorbent Assay (ELISA) is a widely used laboratory research assay designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is a very accurate, highly sensitive and specific immunoassay in comparison to other types of common... - October 03, 2015 - Altogen Labs
Regulate Gene Expression with Altogen Labs RNAi Technology
Ribonucleic Acid or RNA is a molecule critical to biology because it is behind the coding, regulation and expression of genes. With the RNA Interference or RNAi technology service offered by Altogen Labs it is possible to effectively regulate gene expression. Moreover, Altogen Labs has developed... - October 03, 2015 - Altogen Labs
Novatein Biosciences Launches Cancer Biomarker ELISA Kits
Novatein Biosciences (www.novateinbio.com) is proud to add Cancer Biomarker ELISA Kits to its expanding product line. - October 03, 2015 - Novatein Biosciences
Altogen Biosystems Releases Competitive In Vivo Polymer Kit
Altogen Biosystems has exclusively developed a highly effective In Vivo Polymer Transfection Kit that is capable of delivering siRNA, mRNA, small proteins, and DNA into various rodent tissues for pre-clinical and laboratory research. The efficacy of the Altogen Biosystems new in vivo transfection... - October 02, 2015 - Altogen Biosystems
New Generation of Tissue-Targeted Nanoparticle Based In Vivo Transfection Kit for Animal Research Developed by Altogen Biosystems
Researchers can now effectively deliver molecular targeted medicines into a myriad of tissues using nanotechnology. Altogen Biosystems has developed a new generation of highly efficient Nanoparticle-based In Vivo Transfection Kit that it exclusively manufactures. Nanoparticle technology can be... - October 02, 2015 - Altogen Biosystems
Altogen Biosystems Offers PEG-Liposome In Vivo Transfection Kit
Altogen Biosystems has developed a highly efficient in vivo transfection reagent capable of delivery cargo molecules (siRNA, miRNA, pDNA, and small proteins) into multiple tissues including spleen, kidney, pancreas, liver, and tumors. In vivo transfection is a laboratory research method utilized by... - October 02, 2015 - Altogen Biosystems
Procyrion's Circulatory Pump for Late-Stage Heart Failure Earns Spot in TCT Interventional Innovation "Shark Tank” Competition
Diagnostic and therapeutic modalities presented at Transcatheter Cardiovascular Therapeutics annual scientific symposium. - October 02, 2015 - Procyrion Inc
Houston Heart Pump Developer Procyrion Inc. Earns $20,000 Grand Prize in "Create the Future" Design Contest
Out of 1,159 forward-thinking engineering innovations from 60 countries, micro heart pump developer Procyrion Inc. of Houston, Texas earned the $20,000 grand prize in the 2015 “Create the Future” Design Contest, organized by the publishers of NASA Tech Briefs and Medical Design Briefs... - October 01, 2015 - Procyrion Inc
Bostonians Walk, Run for Kids with Brain Tumors
About 200 Bostonians gathered on Sept. 26 for the Starry Night Boston 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $27,074 to help fund the foundation’s lifesaving research and life-changing family support programs. The crowd gathered for the... - September 30, 2015 - Pediatric Brain Tumor Foundation
Motorcyclists Contribute $167,000 to Aid Sick Children
From the Las Vegas Strip to the Capitol area, more than 700 motorcyclists gathered for children battling brain tumors over the weekend. As of ride time, the family-friendly Baltimore-Washington and Las Vegas Ride for Kids events had raised $167,459 to support the Pediatric Brain Tumor... - September 30, 2015 - Pediatric Brain Tumor Foundation
Ixogel® is Granted QIDP Status by the US Food and Drug Administration
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the U.S. Food and Drug Administration (FDA) has designated the company's lead product candidate, Ixogel®, as a Qualified Infectious Disease Product (QIDP) for the prevention of Lyme Disease after a tick bite and is working with the company on the phase III protocol. Special Protocol Assessment (SPA) confirmation expected soon. - September 29, 2015 - Ixodes AG
FDA Renews Pinnacle 21 as Software Provider for DataFit
Pinnacle 21 announced today that it has been selected to provide custom software and related services to support the FDA’s DataFit program, which serves to expedite the new drug application process. - September 26, 2015 - Pinnacle 21
Bioo Scientific Releases Automated Small RNA Library Prep Protocol for the Sciclone NGS Workstation
Bioo Scientific has automated bias-reducing small RNA library prep on the Sciclone® NGS and NGSx Workstations, automating the NEXTflex™ Small RNA-Seq Library Prep Kit v2 and increasing productivity by reducing the time and labor costs associated with small RNA library prep. - September 26, 2015 - Bioo Scientific
MoBiTec GmbH to Attend BIOTECHNICA 2015, Germany - See ZDGSY's Inimitable GS-Key, an Amazingly Small and Fast DNA Extraction Device
BIOTECHNICA - Europe's No.1 Event for Biotechnology, Life Sciences, and Lab Technology! At MoBiTec's booth, cutting-edge technologies will be presented. Highlight: An incredibly small and fast handheld device for DNA extraction! - September 25, 2015 - MoBiTec GmbH
Bioo Scientific Showcases Innovative Solutions for Rapid Food Safety Testing at AOAC 2015
Bioo Scientific will exhibit its latest advances in food and feed safety and quality testing, at booth #502 of the 129th AOAC Annual Meeting, September 27-30 in Los Angeles, CA. New technologies include the most sensitive test available for histamine screening, a sulfite detection method which overcomes issues with problematic “high-creep” samples, optimized immunoaffinity columns for mycotoxin analysis, and a solution for high-throughput detection of amantadine residues in poultry. - September 25, 2015 - Bioo Scientific
Bioo Scientific Launches Enzymatic Assay for Accurate Homocysteine Analysis in Model Organisms
Bioo Scientific has released the MaxDiscovery™ Homocysteine Enzymatic Assay Kit. This kit uses a new enzymatic technology for spectrophotometric detection of total homocysteine levels in serum from rodents and other mammals. This kit enables the determination of hyperhomocysteinemia, or elevated levels of total homocysteine (tHcy) in the blood, which is an independent risk factor for neural tube defects, vascular diseases and Alzheimer’s disease, and other diseases. - September 23, 2015 - Bioo Scientific
Golden State Motorcyclists Ride for Kids with Brain Tumors
More than 330 motorcyclists gathered for children battling brain tumors at the San Diego Ride for Kids event over the weekend. As of ride time, this motorcycle event had raised $35,912 to support the Pediatric Brain Tumor Foundation. The event at Mira Costa College in Cardiff honored four local... - September 23, 2015 - Pediatric Brain Tumor Foundation
Philadelphia Athletes Complete 8.5k for Kids with Brain Tumors
The City of Brotherly Love welcomed about 750 walkers and runners on Sept. 19 for the Philadelphia Starry Night 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $47,974 to help fund the foundation’s lifesaving research and life-changing family... - September 23, 2015 - Pediatric Brain Tumor Foundation
Marriage of Science and Marketing Makes Beautiful Skin Affordable
RxGenesys blends high-end stem cell tech with smart distribution and devoted customers to bring celebrity beauty secrets to real women -- on a budget. Less than three minutes and $1.50 a day visibly improve the skin’s appearance. When Sports Illustrated goddess Paulina Porizkova burst onto... - September 21, 2015 - RxGenesys
Miami-Based RxGenesys, LLC Raises 4 Million in Series B Funding
With funding and proven results, RxGenesys has partnered with marketing mogul and Shark Tank celebrity Kevin Harrington, who will spearhead the company’s Direct Response Campaign. “I’ve seen a lot of products and a lot of business plans, I joined the RxGenesys initiative because a direct response strategy using a prestige product like this is fresh and absolutely ideal to capture the growing market for products that look and feel like a celebrity insider secret,” Harrington said. - September 21, 2015 - RxGenesys
Experiments to Boost Procyrion's Micro Heart Pump Presented at Scientific Conference
enmodes GmbH, a German company that designs and engineers innovative medical designs, put Houston-based Procyrion Inc.’s Aortix™ micro heart pump through a series of computational fluid dynamic simulations to improve the overall design and performance of the prototype in preparation for... - September 19, 2015 - Procyrion Inc
MoBiTec to Offer ProteoGREEN™-gGlu, a Fluorogenic Probe for Specific Detection of Cancer Cells
ProteoGREEN™-gGlu is a cancer-selective fluorogenic imaging probe that is rapidly activated to a highly fluorescent compound. The membrane-permeable dye is suitable for live cells or in vivo imaging of cancer cells. - September 18, 2015 - MoBiTec GmbH
MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of... - September 17, 2015 - Cayman Chemical Company
Motorcyclists from Coast to Coast Ride for Kids with Brain Tumors
Motorcyclists from Birmingham, Philadelphia and Puget Sound hit the road for children battling brain tumors during Ride for Kids events over the weekend. These family-friendly motorcycle events, held in Leeds, Ala., Phoenixville, Pa., Carnation, Wash., raised more than $150,000 to support the... - September 16, 2015 - Pediatric Brain Tumor Foundation
Novatein Biosciences (NovaTeinBio.com) Launches Food ELISA Kits
Novatein Biosciences (www.novateinbio.com) continues to expand its product line with the launch of food ELISA kits. - September 12, 2015 - Novatein Biosciences
Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener™ Epigenetic Methylation Test
The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming detection analyte probes based on a natural product mimic of the methyltransferase cofactor S-adenosylmethionine (SAM). Aptly named SAM-Screener™, these probes are the foundation of Cayman’s high-throughput, one-step florescent binding assays for identification of SAM-competitive methyltransferase inhibitors from small-molecule chemical libraries. - September 10, 2015 - Cayman Chemical Company
Bioo Scientific Receives USDA Approval for Using Its ELISA to Screen Meat for Ractopamine Residues
Bioo Scientific’s MaxSignal® Ractopamine ELISA Test Kit has been approved by the USDA for the verification testing requirements for screening of meat in the Quality System Verification Program (QSVP), Never Fed Beta-Agonists Marketing Program. The kit enables the detection of as little as 0.1 ppb of ractopamine in pork and other meat samples, well below the 1 ppb minimal required performance limit used by many countries. - September 04, 2015 - Bioo Scientific
NASH Drugs Market, 2015-2025
The "NASH Drugs Market, 2015-2025" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of molecules in this area. With an expanding NAFLD and NASH population worldwide, there is a growing need for development of therapeutics in this disease area. - September 03, 2015 - Roots Analysis
Protein Expression Systems Market: Current Landscape and Future Opportunities
Advances in genetic engineering and cloning techniques have allowed isolation and expression of heterologous and recombinant proteins for research, therapeutic and industrial uses. Large scale applications such as enzyme, antibody or vaccine production require high amounts of protein. This demands that the system producing protein must be easy to culture, allow rapid cell growth and provide good yield. - September 02, 2015 - Roots Analysis
NanoCellect and UCSD Team Up on Single-Cell Sorting and Analysis
NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life science researchers, begins a collaboration with UCSD to develop single cell applications based on their WOLF Cell Sorter. The WOLF Cell Sorter enables easy-to-use cell sorting that... - September 02, 2015 - NanoCellect
VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend
The Cognitive Health Online Summit will occur on September 2, 2015, and will feature Philip Bromley discussing Smart Delivery Technologies. VIRUN signs a lease for a new R&D facility in Pomona, California. SupplySide West Expo 2015 is right around the corner, and VIRUN is sure to be a crowd pleaser as it goes back in time to deliver the future of functional beverages. VIRUN has added a “Shop VIRUN” page to proliferate the VIRUN phenomenon. - September 01, 2015 - VIRUN
Epitope Diagnostics Introduces Novel Fecal NGAL Specific ELISA Kit for Inflammatory Bowel Disease
Epitope Diagnostics introduces its novel fecal neutrophil gelatinase-associated lipocalin (NGAL) ELISA kit. This is the first commercial kit that is developed for measurement of NGAL levels in human stool sample. Fecal NGAL is potentially a better marker than those currently used in clinical practice. - September 01, 2015 - Epitope Diagnostics, Inc.
KinderPharm LLC Acquires Clinical Pharmacology and Pharmacometric Research and Development Company
KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC
Keynote Line-Up and Seven FDA Speakers Confirmed for Immunogenicity and Bioassay Summit 2015, Organized by Cambridge Healthtech Institute
Seventh annual event to focus on technologies and strategies for safe and efficacious products in the clinic. - August 31, 2015 - Cambridge Healthtech Institute
Bioo Scientific Honored for Increasing Austin’s Ability to Compete in the Global Marketplace
Bioo Scientific, an Austin-based biotech company which manufactures food and feed safety test kits and products supporting life science research, received the British Airways International Trade, Investment & Expansion Award, which recognizes investments by international companies in Austin that create jobs locally, as well as Austin-based companies who have a global impact through products and services provided worldwide. - August 30, 2015 - Bioo Scientific
Bioo Scientific Enables the Sensitive Detection of a Broad Range of Beta-Lactam Antibiotics in Food
Bioo Scientific’s MaxSignal® Beta-Lactam ELISA Test Kit has been validated for the screening of a wide range of beta-lactam antibiotics in a number of food matrices, with detection limits as low as 0.8 ppb. - August 27, 2015 - Bioo Scientific
Ambu Partners with ValueCentric in Data Enhancement Initiative
Ambu chooses ValueCentric for their expertise in data cleansing and enhanced Master Data Management services. - August 27, 2015 - ValueCentric
New England, North Carolina Motorcyclists Hit Road for Kids
From the mountains of North Carolina to history-rich sites of Massachusetts, motorcyclists hit the road over the weekend for kids battling brain tumors. These family-friendly Ride for Kids events, held in Asheville, N.C., and Framingham, Mass., raised $84,236 to support the Pediatric Brain Tumor... - August 27, 2015 - Pediatric Brain Tumor Foundation
ALPCO Releases New STELLUX® Chemiluminescent Adiponectin ELISAs
ALPCO has launched its new STELLUX® Chemiluminescent Total Adiponectin and HMW Adiponectin ELISAs. - August 25, 2015 - ALPCO
DaVinci Biosciences Announces Publication of "Mesenchymal Stem Cells for the Treatment of Arthritis" in the Book Anti-Aging Therapeutics, Volume 17
DaVinci Biosciences, LLC, a company committed to improving the quality of life for those suffering from degenerative diseases, announced today that the Vice President of Research and Development, Rafael Gonzalez’s, paper “Mesenchymal Stem Cells for the Treatment of Arthritis” has... - August 25, 2015 - DaVinci Biosciences LLC
Molecular Innovations, Inc. Issued U.S. Patent for Human Prorenin ELISA Kit
Molecular Innovations, Inc. has been issued United States Patent Number 9,085,795 for its unique and novel “Human Prorenin ELISA Kit.” - August 23, 2015 - Molecular Innovations